Rank | Gene Set | Z-score |
---|---|---|
1 | sarcomere organization (GO:0045214) | 7.23368682 |
2 | cardiac myofibril assembly (GO:0055003) | 7.22162198 |
3 | myofibril assembly (GO:0030239) | 6.65873676 |
4 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 6.43972256 |
5 | actin-myosin filament sliding (GO:0033275) | 6.23713182 |
6 | muscle filament sliding (GO:0030049) | 6.23713182 |
7 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 5.94548268 |
8 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 5.88220259 |
9 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 5.79567571 |
10 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 5.73663244 |
11 | regulation of skeletal muscle contraction (GO:0014819) | 5.58968529 |
12 | carnitine shuttle (GO:0006853) | 5.47771007 |
13 | tricarboxylic acid cycle (GO:0006099) | 5.38895712 |
14 | cardiac muscle contraction (GO:0060048) | 5.37161628 |
15 | actin-mediated cell contraction (GO:0070252) | 5.23457427 |
16 | plasma membrane repair (GO:0001778) | 5.16452659 |
17 | regulation of actin filament-based movement (GO:1903115) | 5.16155833 |
18 | regulation of relaxation of muscle (GO:1901077) | 5.09083737 |
19 | fatty acid transmembrane transport (GO:1902001) | 5.07996021 |
20 | cardiac muscle cell development (GO:0055013) | 5.05365304 |
21 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 5.03618686 |
22 | heart trabecula formation (GO:0060347) | 4.79543432 |
23 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 4.77912974 |
24 | actomyosin structure organization (GO:0031032) | 4.77787548 |
25 | cardiac cell development (GO:0055006) | 4.75968654 |
26 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 4.73706662 |
27 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 4.73313903 |
28 | cardiac muscle tissue morphogenesis (GO:0055008) | 4.67125227 |
29 | ventricular cardiac muscle cell action potential (GO:0086005) | 4.65523854 |
30 | regulation of sarcomere organization (GO:0060297) | 4.62954157 |
31 | cardiac muscle hypertrophy (GO:0003300) | 4.61020689 |
32 | regulation of cell communication by electrical coupling (GO:0010649) | 4.59317341 |
33 | lymph vessel development (GO:0001945) | 4.58373346 |
34 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 4.58143034 |
35 | ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 4.48723651 |
36 | striated muscle contraction (GO:0006941) | 4.47763846 |
37 | behavioral response to nicotine (GO:0035095) | 4.47470227 |
38 | striated muscle hypertrophy (GO:0014897) | 4.42972956 |
39 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 4.38886324 |
40 | vascular endothelial growth factor signaling pathway (GO:0038084) | 4.36345889 |
41 | adult heart development (GO:0007512) | 4.27688131 |
42 | muscle tissue morphogenesis (GO:0060415) | 4.27385173 |
43 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 4.26610105 |
44 | indole-containing compound catabolic process (GO:0042436) | 4.22390794 |
45 | indolalkylamine catabolic process (GO:0046218) | 4.22390794 |
46 | tryptophan catabolic process (GO:0006569) | 4.22390794 |
47 | regulation of striated muscle contraction (GO:0006942) | 4.19613235 |
48 | carnitine transmembrane transport (GO:1902603) | 4.08187830 |
49 | gamma-aminobutyric acid transport (GO:0015812) | 4.04486872 |
50 | kynurenine metabolic process (GO:0070189) | 3.98786393 |
51 | regulation of sequestering of triglyceride (GO:0010889) | 3.97993900 |
52 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 3.97879482 |
53 | actin filament-based movement (GO:0030048) | 3.96780538 |
54 | muscle hypertrophy (GO:0014896) | 3.94540795 |
55 | cell communication involved in cardiac conduction (GO:0086065) | 3.91349592 |
56 | regulation of membrane repolarization (GO:0060306) | 3.87578809 |
57 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.84779990 |
58 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.83104869 |
59 | heart process (GO:0003015) | 3.82598967 |
60 | heart contraction (GO:0060047) | 3.82598967 |
61 | 2-oxoglutarate metabolic process (GO:0006103) | 3.82532525 |
62 | regulation of cofactor metabolic process (GO:0051193) | 3.79794674 |
63 | regulation of coenzyme metabolic process (GO:0051196) | 3.79794674 |
64 | amino-acid betaine transport (GO:0015838) | 3.74196051 |
65 | carnitine transport (GO:0015879) | 3.74196051 |
66 | regulation of the force of heart contraction (GO:0002026) | 3.72180512 |
67 | indolalkylamine metabolic process (GO:0006586) | 3.69013172 |
68 | interkinetic nuclear migration (GO:0022027) | 3.67392795 |
69 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 3.63669618 |
70 | regulation of cardiac muscle cell contraction (GO:0086004) | 3.61630130 |
71 | creatine metabolic process (GO:0006600) | 3.60606367 |
72 | sulfation (GO:0051923) | 3.60486882 |
73 | cAMP catabolic process (GO:0006198) | 3.60314631 |
74 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.54426946 |
75 | cellular ketone body metabolic process (GO:0046950) | 3.53250442 |
76 | regulation of cardiac muscle contraction (GO:0055117) | 3.50209076 |
77 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 3.49320085 |
78 | cardiac muscle cell action potential (GO:0086001) | 3.49033801 |
79 | cardiac muscle cell action potential involved in contraction (GO:0086002) | 3.46625059 |
80 | fatty acid beta-oxidation (GO:0006635) | 3.45731203 |
81 | tryptophan metabolic process (GO:0006568) | 3.43294977 |
82 | relaxation of cardiac muscle (GO:0055119) | 3.42237060 |
83 | skeletal muscle contraction (GO:0003009) | 3.41660129 |
84 | fucose catabolic process (GO:0019317) | 3.40309842 |
85 | L-fucose metabolic process (GO:0042354) | 3.40309842 |
86 | L-fucose catabolic process (GO:0042355) | 3.40309842 |
87 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 3.36644425 |
88 | lysine catabolic process (GO:0006554) | 3.35582252 |
89 | lysine metabolic process (GO:0006553) | 3.35582252 |
90 | regulation of fatty acid oxidation (GO:0046320) | 3.35130803 |
91 | cyclic nucleotide catabolic process (GO:0009214) | 3.33311257 |
92 | lymphangiogenesis (GO:0001946) | 3.33283592 |
93 | cardiac muscle adaptation (GO:0014887) | 3.32404983 |
94 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 3.32404983 |
95 | muscle hypertrophy in response to stress (GO:0003299) | 3.32404983 |
96 | NADH metabolic process (GO:0006734) | 3.31249911 |
97 | regulation of heart rate (GO:0002027) | 3.27880672 |
98 | cell communication by electrical coupling (GO:0010644) | 3.27385768 |
99 | muscle contraction (GO:0006936) | 3.26977557 |
100 | negative regulation of cardiac muscle cell apoptotic process (GO:0010667) | 3.26814950 |
101 | regulation of sulfur metabolic process (GO:0042762) | 3.24954913 |
102 | regulation of hippo signaling (GO:0035330) | 3.23627123 |
103 | negative regulation of potassium ion transport (GO:0043267) | 3.23350111 |
104 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 3.21972980 |
105 | trabecula formation (GO:0060343) | 3.20290340 |
106 | neuronal action potential (GO:0019228) | 3.20010884 |
107 | aspartate family amino acid catabolic process (GO:0009068) | 3.19989476 |
108 | reflex (GO:0060004) | 3.19942697 |
109 | serotonin metabolic process (GO:0042428) | 3.16614933 |
110 | negative regulation of protein localization to cell surface (GO:2000009) | 3.15141101 |
111 | indole-containing compound metabolic process (GO:0042430) | 3.12251861 |
112 | ketone body metabolic process (GO:1902224) | 3.10987807 |
113 | muscle system process (GO:0003012) | 3.10125860 |
114 | striated muscle adaptation (GO:0014888) | 3.07653103 |
115 | skeletal muscle adaptation (GO:0043501) | 3.05661757 |
116 | primary amino compound metabolic process (GO:1901160) | 3.04283559 |
117 | striated muscle cell development (GO:0055002) | 3.02198986 |
118 | regulation of gene silencing by RNA (GO:0060966) | 3.01721783 |
119 | regulation of posttranscriptional gene silencing (GO:0060147) | 3.01721783 |
120 | regulation of gene silencing by miRNA (GO:0060964) | 3.01721783 |
121 | cardiac conduction (GO:0061337) | 3.00530861 |
122 | glycogen catabolic process (GO:0005980) | 3.00471602 |
123 | behavioral response to ethanol (GO:0048149) | 2.96455780 |
124 | regulation of heart contraction (GO:0008016) | 2.95209063 |
125 | regulation of action potential (GO:0098900) | 2.94593725 |
126 | regulation of cardioblast differentiation (GO:0051890) | 2.93482118 |
127 | positive regulation of fatty acid oxidation (GO:0046321) | 2.93158810 |
128 | fatty acid oxidation (GO:0019395) | 2.90712163 |
129 | positive regulation of heart rate (GO:0010460) | 2.90704776 |
130 | membrane depolarization during action potential (GO:0086010) | 2.89601909 |
131 | response to inactivity (GO:0014854) | 2.89294664 |
132 | succinate metabolic process (GO:0006105) | 2.87527887 |
133 | regulation of muscle contraction (GO:0006937) | 2.87520087 |
134 | amine catabolic process (GO:0009310) | 2.86995918 |
135 | cellular biogenic amine catabolic process (GO:0042402) | 2.86995918 |
136 | negative regulation of sodium ion transport (GO:0010766) | 2.80347250 |
137 | signal peptide processing (GO:0006465) | 2.78885598 |
138 | atrial cardiac muscle cell action potential (GO:0086014) | 2.77520196 |
139 | positive regulation of action potential (GO:0045760) | 2.75389187 |
140 | NAD biosynthetic process (GO:0009435) | 2.74156925 |
141 | oxidative demethylation (GO:0070989) | 2.70848110 |
142 | regulation of mesoderm development (GO:2000380) | 2.66363412 |
143 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.66250148 |
144 | negative regulation of translation, ncRNA-mediated (GO:0040033) | 2.62628012 |
145 | regulation of translation, ncRNA-mediated (GO:0045974) | 2.62628012 |
146 | negative regulation of translation involved in gene silencing by miRNA (GO:0035278) | 2.62628012 |
147 | detection of light stimulus involved in visual perception (GO:0050908) | 2.58421713 |
148 | detection of light stimulus involved in sensory perception (GO:0050962) | 2.58421713 |
149 | cellular response to sterol (GO:0036315) | 2.56649125 |
150 | flavonoid metabolic process (GO:0009812) | 2.54617968 |
151 | nephron tubule morphogenesis (GO:0072078) | 2.52663586 |
152 | nephron epithelium morphogenesis (GO:0072088) | 2.52663586 |
153 | action potential (GO:0001508) | 2.51959572 |
154 | drug catabolic process (GO:0042737) | 2.50758087 |
155 | benzene-containing compound metabolic process (GO:0042537) | 2.50224442 |
156 | renal tubule morphogenesis (GO:0061333) | 2.49728301 |
157 | alanine transport (GO:0032328) | 2.49154447 |
158 | peristalsis (GO:0030432) | 2.48315212 |
159 | aromatic amino acid family catabolic process (GO:0009074) | 2.48062561 |
160 | cilium or flagellum-dependent cell motility (GO:0001539) | 2.44815958 |
161 | exogenous drug catabolic process (GO:0042738) | 2.43118623 |
162 | regulation of establishment of cell polarity (GO:2000114) | 2.42805583 |
163 | regulation of establishment or maintenance of cell polarity (GO:0032878) | 2.42567728 |
164 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 2.39732546 |
165 | transmission of nerve impulse (GO:0019226) | 2.39221670 |
166 | cochlea development (GO:0090102) | 2.37694798 |
167 | urinary tract smooth muscle contraction (GO:0014848) | 2.37098536 |
168 | response to caffeine (GO:0031000) | 2.36906697 |
169 | kidney morphogenesis (GO:0060993) | 2.35856177 |
170 | inner ear receptor stereocilium organization (GO:0060122) | 2.35136298 |
171 | cell morphogenesis involved in neuron differentiation (GO:0048667) | 2.34474114 |
172 | spinal cord motor neuron differentiation (GO:0021522) | 2.33568629 |
173 | auditory receptor cell stereocilium organization (GO:0060088) | 2.32814086 |
174 | nucleus localization (GO:0051647) | 2.32805821 |
175 | regulation of pigment cell differentiation (GO:0050932) | 2.32083207 |
176 | somite development (GO:0061053) | 2.30931128 |
177 | negative regulation of mast cell activation (GO:0033004) | 2.30474497 |
178 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.29263016 |
179 | cardiovascular system development (GO:0072358) | 2.28898431 |
180 | negative regulation of axon guidance (GO:1902668) | 2.28807027 |
181 | proline transport (GO:0015824) | 2.27200660 |
182 | negative regulation of axon extension involved in axon guidance (GO:0048843) | 2.27045652 |
183 | positive regulation of sodium ion transmembrane transport (GO:1902307) | 2.26138253 |
184 | synaptic transmission, cholinergic (GO:0007271) | 2.24423977 |
185 | striated muscle atrophy (GO:0014891) | 2.24162683 |
186 | detection of mechanical stimulus involved in sensory perception (GO:0050974) | 2.23804663 |
187 | presynaptic membrane assembly (GO:0097105) | 2.23568235 |
Rank | Gene Set | Z-score |
---|---|---|
1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 6.19605353 |
2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.27596861 |
3 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 3.94947878 |
4 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.74612756 |
5 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.49315626 |
6 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 3.04662304 |
7 | VDR_22108803_ChIP-Seq_LS180_Human | 3.02655488 |
8 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 3.02047679 |
9 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 3.02047679 |
10 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 3.00177456 |
11 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.95488884 |
12 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.70729672 |
13 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.67287559 |
14 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.55022068 |
15 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.49989751 |
16 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.44405962 |
17 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.43985121 |
18 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.43547428 |
19 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.30887191 |
20 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.28818762 |
21 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.26452492 |
22 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.25899677 |
23 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.24992891 |
24 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.24626578 |
25 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.18706463 |
26 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.16194776 |
27 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.07541441 |
28 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 2.06258738 |
29 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.00933594 |
30 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.97854030 |
31 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.95273151 |
32 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.92483439 |
33 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.91166161 |
34 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.90878306 |
35 | P300_19829295_ChIP-Seq_ESCs_Human | 1.88609663 |
36 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.86528304 |
37 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.85813896 |
38 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.84937827 |
39 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.80777710 |
40 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.74619252 |
41 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.73348163 |
42 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.72486861 |
43 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.71396866 |
44 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.70018688 |
45 | FUS_26573619_Chip-Seq_HEK293_Human | 1.69842461 |
46 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.69571067 |
47 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.68533761 |
48 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.65293515 |
49 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.62870252 |
50 | EWS_26573619_Chip-Seq_HEK293_Human | 1.62314755 |
51 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.62183723 |
52 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.61575359 |
53 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.61208908 |
54 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.60417436 |
55 | AR_25329375_ChIP-Seq_VCAP_Human | 1.54958909 |
56 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.54323874 |
57 | TCF4_23295773_ChIP-Seq_U87_Human | 1.53706300 |
58 | * UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.53636459 |
59 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.53102725 |
60 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.50696062 |
61 | GATA1_22025678_ChIP-Seq_K562_Human | 1.48543898 |
62 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 1.48522275 |
63 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.47088127 |
64 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.45472501 |
65 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.43755554 |
66 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.43755554 |
67 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.42768053 |
68 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.42750893 |
69 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.41847893 |
70 | TP53_16413492_ChIP-PET_HCT116_Human | 1.40858018 |
71 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.40714100 |
72 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.40594849 |
73 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.38399639 |
74 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.37930254 |
75 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.37579401 |
76 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.34750899 |
77 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.33606885 |
78 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.30476024 |
79 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.30191774 |
80 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.29806653 |
81 | CJUN_26792858_Chip-Seq_BT549_Human | 1.26849498 |
82 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.26759782 |
83 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.26759782 |
84 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.25786979 |
85 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.25654993 |
86 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.24630452 |
87 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.23131310 |
88 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.23051703 |
89 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.22866251 |
90 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.22135260 |
91 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.21848191 |
92 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.21087237 |
93 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.20832996 |
94 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.17528594 |
95 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.16132493 |
96 | * TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.15659221 |
97 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.15490896 |
98 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.15431616 |
99 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.15160177 |
100 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.14702833 |
101 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.14509954 |
102 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.14502856 |
103 | GATA1_19941826_ChIP-Seq_K562_Human | 1.14169621 |
104 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.13594850 |
105 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.13458962 |
106 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.13458962 |
107 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.13385226 |
108 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.13307379 |
109 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.13282004 |
110 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.13271627 |
111 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.12289458 |
112 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.11527725 |
113 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.11527725 |
114 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.10881353 |
115 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.10627985 |
116 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.10350424 |
117 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.08881048 |
118 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.08617044 |
119 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.08162338 |
120 | KDM2B_26808549_Chip-Seq_REH_Human | 1.07408456 |
121 | RXR_22108803_ChIP-Seq_LS180_Human | 1.07212403 |
122 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.07069845 |
123 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.06129448 |
124 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.05281971 |
125 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.04807382 |
126 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.03065096 |
127 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.00080427 |
128 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.00067234 |
129 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 0.98238503 |
130 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 0.98238503 |
131 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.97649558 |
132 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.94261898 |
133 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.92656281 |
134 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.92014390 |
135 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.91730446 |
136 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.90314095 |
137 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 0.89633507 |
138 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.89535819 |
139 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.89136587 |
140 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.88811407 |
141 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 0.88514167 |
142 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.87810090 |
143 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.87752825 |
144 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.87601006 |
145 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.87204656 |
146 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.87060136 |
147 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.85605460 |
148 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.85401586 |
149 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.84776453 |
150 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.84491635 |
151 | * CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.84319207 |
152 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.81467182 |
153 | GATA2_19941826_ChIP-Seq_K562_Human | 0.80993540 |
154 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.80841599 |
155 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 0.80836748 |
156 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.80207147 |
157 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.79709367 |
158 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.79642818 |
159 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.79325342 |
160 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.78685948 |
161 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.78547776 |
162 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.78176384 |
163 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 0.77777503 |
164 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.77252389 |
165 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.75093502 |
166 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.74395940 |
167 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.74346931 |
168 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.74021175 |
169 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.72535087 |
170 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.72158434 |
171 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.71945395 |
172 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.71736954 |
173 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.70901735 |
174 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.70428758 |
175 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.69921317 |
176 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.69138863 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002837_dystrophic_cardiac_calcinosis | 5.76894639 |
2 | MP0004084_abnormal_cardiac_muscle | 5.09827915 |
3 | MP0004215_abnormal_myocardial_fiber | 4.78195610 |
4 | MP0003646_muscle_fatigue | 4.77734129 |
5 | MP0000751_myopathy | 4.61159413 |
6 | MP0004036_abnormal_muscle_relaxation | 4.06334742 |
7 | MP0000749_muscle_degeneration | 3.62917986 |
8 | MP0005330_cardiomyopathy | 3.52535335 |
9 | MP0000569_abnormal_digit_pigmentation | 3.24196465 |
10 | MP0010368_abnormal_lymphatic_system | 3.23948062 |
11 | MP0002972_abnormal_cardiac_muscle | 2.83699422 |
12 | MP0004087_abnormal_muscle_fiber | 2.83130097 |
13 | MP0003136_yellow_coat_color | 2.75929867 |
14 | MP0004145_abnormal_muscle_electrophysio | 2.72536580 |
15 | MP0008775_abnormal_heart_ventricle | 2.71986182 |
16 | * MP0005620_abnormal_muscle_contractility | 2.66177330 |
17 | * MP0004130_abnormal_muscle_cell | 2.50145132 |
18 | MP0000750_abnormal_muscle_regeneration | 2.49057278 |
19 | MP0002106_abnormal_muscle_physiology | 2.42112057 |
20 | MP0010630_abnormal_cardiac_muscle | 2.40323534 |
21 | MP0001544_abnormal_cardiovascular_syste | 2.37682354 |
22 | MP0005385_cardiovascular_system_phenoty | 2.37682354 |
23 | MP0001879_abnormal_lymphatic_vessel | 2.35656766 |
24 | MP0009046_muscle_twitch | 2.34925162 |
25 | MP0004484_altered_response_of | 2.31575155 |
26 | MP0006138_congestive_heart_failure | 2.25624962 |
27 | MP0003828_pulmonary_edema | 2.25183023 |
28 | * MP0003137_abnormal_impulse_conducting | 2.18315865 |
29 | MP0001501_abnormal_sleep_pattern | 2.14208145 |
30 | MP0002269_muscular_atrophy | 2.09557003 |
31 | MP0004085_abnormal_heartbeat | 2.00844811 |
32 | MP0009745_abnormal_behavioral_response | 1.99502154 |
33 | MP0005369_muscle_phenotype | 1.99206366 |
34 | MP0005551_abnormal_eye_electrophysiolog | 1.98432811 |
35 | MP0001485_abnormal_pinna_reflex | 1.91521757 |
36 | MP0000747_muscle_weakness | 1.85966677 |
37 | MP0000759_abnormal_skeletal_muscle | 1.84811813 |
38 | MP0005670_abnormal_white_adipose | 1.83959684 |
39 | MP0000013_abnormal_adipose_tissue | 1.83229159 |
40 | MP0001968_abnormal_touch/_nociception | 1.83030270 |
41 | MP0004142_abnormal_muscle_tone | 1.76545329 |
42 | MP0002127_abnormal_cardiovascular_syste | 1.74834700 |
43 | MP0003283_abnormal_digestive_organ | 1.68563841 |
44 | MP0002638_abnormal_pupillary_reflex | 1.68460714 |
45 | MP0004272_abnormal_basement_membrane | 1.67101629 |
46 | MP0006054_spinal_hemorrhage | 1.58466084 |
47 | MP0005666_abnormal_adipose_tissue | 1.57688561 |
48 | MP0002272_abnormal_nervous_system | 1.57665937 |
49 | MP0002332_abnormal_exercise_endurance | 1.57542951 |
50 | MP0001486_abnormal_startle_reflex | 1.56263155 |
51 | MP0004510_myositis | 1.55103018 |
52 | MP0002735_abnormal_chemical_nociception | 1.53472257 |
53 | MP0000427_abnormal_hair_cycle | 1.50207671 |
54 | MP0002064_seizures | 1.48939104 |
55 | MP0005646_abnormal_pituitary_gland | 1.47728517 |
56 | MP0006036_abnormal_mitochondrial_physio | 1.44687290 |
57 | MP0002736_abnormal_nociception_after | 1.44362925 |
58 | MP0003279_aneurysm | 1.41964375 |
59 | MP0002876_abnormal_thyroid_physiology | 1.40799747 |
60 | MP0004885_abnormal_endolymph | 1.40255860 |
61 | MP0003221_abnormal_cardiomyocyte_apopto | 1.39667692 |
62 | MP0002572_abnormal_emotion/affect_behav | 1.38221018 |
63 | MP0005253_abnormal_eye_physiology | 1.37121525 |
64 | MP0006276_abnormal_autonomic_nervous | 1.36010954 |
65 | MP0004233_abnormal_muscle_weight | 1.35090261 |
66 | MP0008438_abnormal_cutaneous_collagen | 1.34446604 |
67 | MP0008872_abnormal_physiological_respon | 1.33037785 |
68 | MP0002733_abnormal_thermal_nociception | 1.31667798 |
69 | MP0002734_abnormal_mechanical_nocicepti | 1.30361840 |
70 | MP0003890_abnormal_embryonic-extraembry | 1.28733263 |
71 | MP0000383_abnormal_hair_follicle | 1.28491905 |
72 | MP0003950_abnormal_plasma_membrane | 1.27468382 |
73 | MP0005165_increased_susceptibility_to | 1.27343850 |
74 | MP0001970_abnormal_pain_threshold | 1.24733514 |
75 | MP0005375_adipose_tissue_phenotype | 1.24246626 |
76 | MP0008877_abnormal_DNA_methylation | 1.23815142 |
77 | MP0001986_abnormal_taste_sensitivity | 1.23787869 |
78 | MP0000343_altered_response_to | 1.23780933 |
79 | MP0005645_abnormal_hypothalamus_physiol | 1.22479819 |
80 | MP0002938_white_spotting | 1.22150726 |
81 | MP0006072_abnormal_retinal_apoptosis | 1.22095278 |
82 | MP0002067_abnormal_sensory_capabilities | 1.18802044 |
83 | MP0000631_abnormal_neuroendocrine_gland | 1.16765424 |
84 | MP0003119_abnormal_digestive_system | 1.16481106 |
85 | MP0003724_increased_susceptibility_to | 1.16194740 |
86 | MP0004185_abnormal_adipocyte_glucose | 1.15701744 |
87 | MP0003635_abnormal_synaptic_transmissio | 1.15518250 |
88 | MP0004133_heterotaxia | 1.15443675 |
89 | MP0004924_abnormal_behavior | 1.15036118 |
90 | MP0005386_behavior/neurological_phenoty | 1.15036118 |
91 | MP0005174_abnormal_tail_pigmentation | 1.14534778 |
92 | MP0000266_abnormal_heart_morphology | 1.14217334 |
93 | MP0003567_abnormal_fetal_cardiomyocyte | 1.12742129 |
94 | MP0010386_abnormal_urinary_bladder | 1.12700957 |
95 | MP0000003_abnormal_adipose_tissue | 1.10466791 |
96 | MP0002108_abnormal_muscle_morphology | 1.08974541 |
97 | MP0002928_abnormal_bile_duct | 1.08973329 |
98 | MP0005171_absent_coat_pigmentation | 1.08491752 |
99 | MP0003011_delayed_dark_adaptation | 1.07291884 |
100 | MP0005085_abnormal_gallbladder_physiolo | 1.05149963 |
101 | MP0005623_abnormal_meninges_morphology | 1.01784298 |
102 | MP0002063_abnormal_learning/memory/cond | 1.01563158 |
103 | MP0002128_abnormal_blood_circulation | 1.01159709 |
104 | MP0008004_abnormal_stomach_pH | 1.00178803 |
105 | MP0008875_abnormal_xenobiotic_pharmacok | 0.99728115 |
106 | MP0000538_abnormal_urinary_bladder | 0.96202193 |
107 | MP0001984_abnormal_olfaction | 0.95588097 |
108 | MP0002557_abnormal_social/conspecific_i | 0.95547881 |
109 | MP0002102_abnormal_ear_morphology | 0.94957571 |
110 | MP0000026_abnormal_inner_ear | 0.92563857 |
111 | MP0005167_abnormal_blood-brain_barrier | 0.92367203 |
112 | MP0005448_abnormal_energy_balance | 0.92109413 |
113 | MP0000767_abnormal_smooth_muscle | 0.91917581 |
114 | MP0008961_abnormal_basal_metabolism | 0.90709268 |
115 | MP0005275_abnormal_skin_tensile | 0.90182073 |
116 | MP0002909_abnormal_adrenal_gland | 0.89556707 |
117 | MP0004147_increased_porphyrin_level | 0.89162839 |
118 | MP0005423_abnormal_somatic_nervous | 0.87950490 |
119 | MP0001664_abnormal_digestion | 0.86959128 |
120 | MP0001440_abnormal_grooming_behavior | 0.86400683 |
121 | * MP0000230_abnormal_systemic_arterial | 0.84191843 |
122 | MP0003705_abnormal_hypodermis_morpholog | 0.81562036 |
123 | MP0002653_abnormal_ependyma_morphology | 0.80207192 |
124 | MP0004742_abnormal_vestibular_system | 0.79312687 |
125 | MP0002009_preneoplasia | 0.78894390 |
126 | MP0004270_analgesia | 0.78636953 |
127 | MP0003937_abnormal_limbs/digits/tail_de | 0.77694641 |
128 | MP0005195_abnormal_posterior_eye | 0.77586798 |
129 | MP0002971_abnormal_brown_adipose | 0.76140876 |
130 | MP0003566_abnormal_cell_adhesion | 0.74441290 |
131 | MP0003806_abnormal_nucleotide_metabolis | 0.72194166 |
132 | MP0005319_abnormal_enzyme/_coenzyme | 0.70314914 |
133 | MP0005266_abnormal_metabolism | 0.68618184 |
134 | MP0005365_abnormal_bile_salt | 0.67514866 |
135 | MP0006035_abnormal_mitochondrial_morpho | 0.66275434 |
136 | MP0000733_abnormal_muscle_development | 0.64164362 |
137 | MP0002925_abnormal_cardiovascular_devel | 0.61395067 |
138 | MP0009384_cardiac_valve_regurgitation | 0.60326824 |
139 | MP0005360_urolithiasis | 0.58496419 |
140 | MP0010329_abnormal_lipoprotein_level | 0.58248781 |
141 | MP0003252_abnormal_bile_duct | 0.56501499 |
142 | MP0002234_abnormal_pharynx_morphology | 0.55348981 |
143 | * MP0001614_abnormal_blood_vessel | 0.55013220 |
144 | MP0002118_abnormal_lipid_homeostasis | 0.54500424 |
145 | * MP0002078_abnormal_glucose_homeostasis | 0.50332743 |
146 | MP0005332_abnormal_amino_acid | 0.48384867 |
147 | MP0000249_abnormal_blood_vessel | 0.47794781 |
148 | MP0005451_abnormal_body_composition | 0.46241304 |
149 | MP0005187_abnormal_penis_morphology | 0.45879192 |
150 | MP0002139_abnormal_hepatobiliary_system | 0.45089592 |
151 | MP0001784_abnormal_fluid_regulation | 0.43578492 |
152 | * MP0005595_abnormal_vascular_smooth | 0.42874388 |
153 | MP0005503_abnormal_tendon_morphology | 0.42432416 |
154 | MP0002295_abnormal_pulmonary_circulatio | 0.42277546 |
155 | MP0003045_fibrosis | 0.41637795 |
156 | MP0001958_emphysema | 0.41483504 |
157 | MP0003300_gastrointestinal_ulcer | 0.40672826 |
158 | MP0005334_abnormal_fat_pad | 0.38919555 |
159 | MP0001661_extended_life_span | 0.38860475 |
160 | MP0004043_abnormal_pH_regulation | 0.38735779 |
161 | MP0003195_calcinosis | 0.37768524 |
162 | MP0005083_abnormal_biliary_tract | 0.34951487 |
163 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.34821878 |
164 | MP0000609_abnormal_liver_physiology | 0.34623079 |
165 | MP0003191_abnormal_cellular_cholesterol | 0.33776015 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Sudden death (HP:0001699) | 7.50724120 |
2 | Exercise-induced myalgia (HP:0003738) | 6.16141643 |
3 | Calf muscle hypertrophy (HP:0008981) | 6.08791069 |
4 | Exercise-induced muscle cramps (HP:0003710) | 5.95050873 |
5 | * Ventricular tachycardia (HP:0004756) | 5.87659842 |
6 | Muscle fiber splitting (HP:0003555) | 5.81851957 |
7 | Muscle hypertrophy of the lower extremities (HP:0008968) | 5.77566460 |
8 | * Atrial fibrillation (HP:0005110) | 5.09440419 |
9 | Myoglobinuria (HP:0002913) | 5.02165418 |
10 | Hyporeflexia of lower limbs (HP:0002600) | 5.00288827 |
11 | Abnormality of the calf musculature (HP:0001430) | 4.92118527 |
12 | * Lipoatrophy (HP:0100578) | 4.76224148 |
13 | Right ventricular cardiomyopathy (HP:0011663) | 4.74800156 |
14 | * Primary atrial arrhythmia (HP:0001692) | 4.70825054 |
15 | Pancreatic cysts (HP:0001737) | 4.69943523 |
16 | Hyperventilation (HP:0002883) | 4.65442454 |
17 | Subaortic stenosis (HP:0001682) | 4.51946865 |
18 | Abnormality of the left ventricular outflow tract (HP:0011103) | 4.51946865 |
19 | * Supraventricular tachycardia (HP:0004755) | 4.51818211 |
20 | Increased connective tissue (HP:0009025) | 4.50617879 |
21 | * Supraventricular arrhythmia (HP:0005115) | 4.50198434 |
22 | Syncope (HP:0001279) | 4.47534542 |
23 | True hermaphroditism (HP:0010459) | 4.33781669 |
24 | Pancreatic fibrosis (HP:0100732) | 4.25782623 |
25 | Genetic anticipation (HP:0003743) | 4.25443871 |
26 | EMG: myopathic abnormalities (HP:0003458) | 4.14304894 |
27 | Molar tooth sign on MRI (HP:0002419) | 4.00608589 |
28 | Abnormality of midbrain morphology (HP:0002418) | 4.00608589 |
29 | * Dilated cardiomyopathy (HP:0001644) | 3.94703566 |
30 | Difficulty running (HP:0009046) | 3.92699727 |
31 | Bundle branch block (HP:0011710) | 3.90917087 |
32 | Rhabdomyolysis (HP:0003201) | 3.90156118 |
33 | Palpitations (HP:0001962) | 3.89670695 |
34 | Prolonged QT interval (HP:0001657) | 3.83817118 |
35 | Progressive cerebellar ataxia (HP:0002073) | 3.75788664 |
36 | Type 1 muscle fiber predominance (HP:0003803) | 3.75388140 |
37 | Asymmetric septal hypertrophy (HP:0001670) | 3.69007308 |
38 | Ventricular arrhythmia (HP:0004308) | 3.65018247 |
39 | Nephronophthisis (HP:0000090) | 3.46818663 |
40 | Heart block (HP:0012722) | 3.39983165 |
41 | Myotonia (HP:0002486) | 3.39492330 |
42 | Muscle fiber inclusion bodies (HP:0100299) | 3.38456902 |
43 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 3.32774357 |
44 | Atrioventricular block (HP:0001678) | 3.29817693 |
45 | Gaze-evoked nystagmus (HP:0000640) | 3.28548686 |
46 | Protruding tongue (HP:0010808) | 3.21093592 |
47 | Abnormal atrioventricular conduction (HP:0005150) | 3.20235516 |
48 | Cystic liver disease (HP:0006706) | 3.17531589 |
49 | Abnormality of the renal cortex (HP:0011035) | 3.16016232 |
50 | Abnormality of the renal medulla (HP:0100957) | 3.14707884 |
51 | Increased variability in muscle fiber diameter (HP:0003557) | 3.13174673 |
52 | Hypoglycemic coma (HP:0001325) | 3.12949606 |
53 | Clumsiness (HP:0002312) | 3.12679319 |
54 | Ventricular fibrillation (HP:0001663) | 3.07764694 |
55 | Fair hair (HP:0002286) | 3.05976966 |
56 | Inability to walk (HP:0002540) | 3.05689298 |
57 | Congenital stationary night blindness (HP:0007642) | 3.03031446 |
58 | Muscle stiffness (HP:0003552) | 3.00625213 |
59 | Ketoacidosis (HP:0001993) | 2.97500292 |
60 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.92305567 |
61 | Attenuation of retinal blood vessels (HP:0007843) | 2.90079201 |
62 | Increased corneal curvature (HP:0100692) | 2.85880691 |
63 | Keratoconus (HP:0000563) | 2.85880691 |
64 | Type II lissencephaly (HP:0007260) | 2.84802016 |
65 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 2.82622755 |
66 | Medial flaring of the eyebrow (HP:0010747) | 2.78379241 |
67 | Difficulty climbing stairs (HP:0003551) | 2.75559392 |
68 | Abnormal EKG (HP:0003115) | 2.68598854 |
69 | Nemaline bodies (HP:0003798) | 2.68395539 |
70 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.66071103 |
71 | Hemiparesis (HP:0001269) | 2.64253736 |
72 | Chronic hepatic failure (HP:0100626) | 2.62317232 |
73 | Broad-based gait (HP:0002136) | 2.60739591 |
74 | Tubular atrophy (HP:0000092) | 2.58760101 |
75 | Birth length less than 3rd percentile (HP:0003561) | 2.57536801 |
76 | Dicarboxylic aciduria (HP:0003215) | 2.51391745 |
77 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.51391745 |
78 | Abolished electroretinogram (ERG) (HP:0000550) | 2.50518676 |
79 | Hepatic necrosis (HP:0002605) | 2.49075394 |
80 | Febrile seizures (HP:0002373) | 2.48536638 |
81 | * Furrowed tongue (HP:0000221) | 2.46696758 |
82 | Lymphangioma (HP:0100764) | 2.45599794 |
83 | Congenital hepatic fibrosis (HP:0002612) | 2.44146742 |
84 | Areflexia of lower limbs (HP:0002522) | 2.42902391 |
85 | Hypoalphalipoproteinemia (HP:0003233) | 2.42755766 |
86 | Ketosis (HP:0001946) | 2.42090452 |
87 | Congenital sensorineural hearing impairment (HP:0008527) | 2.41349851 |
88 | Distal lower limb muscle weakness (HP:0009053) | 2.41179229 |
89 | Neck muscle weakness (HP:0000467) | 2.40473618 |
90 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 2.39898456 |
91 | Decreased circulating renin level (HP:0003351) | 2.38101444 |
92 | Progressive inability to walk (HP:0002505) | 2.37878095 |
93 | Gait imbalance (HP:0002141) | 2.32883237 |
94 | Sclerocornea (HP:0000647) | 2.32672464 |
95 | Generalized hypopigmentation of hair (HP:0011358) | 2.31450723 |
96 | Facial diplegia (HP:0001349) | 2.28977450 |
97 | Chorioretinal atrophy (HP:0000533) | 2.25864302 |
98 | * Left ventricular hypertrophy (HP:0001712) | 2.22439593 |
99 | Absent/shortened dynein arms (HP:0200106) | 2.21644637 |
100 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.21644637 |
101 | Anencephaly (HP:0002323) | 2.21053848 |
102 | Congenital primary aphakia (HP:0007707) | 2.18897089 |
103 | Pheochromocytoma (HP:0002666) | 2.18320070 |
104 | * Palmoplantar keratoderma (HP:0000982) | 2.17719567 |
105 | Nonimmune hydrops fetalis (HP:0001790) | 2.17299228 |
106 | Genital tract atresia (HP:0001827) | 2.16921778 |
107 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.14180703 |
108 | Abnormality of binocular vision (HP:0011514) | 2.13769089 |
109 | Diplopia (HP:0000651) | 2.13769089 |
110 | Male pseudohermaphroditism (HP:0000037) | 2.13745660 |
111 | Renal cortical cysts (HP:0000803) | 2.13401917 |
112 | Mesangial abnormality (HP:0001966) | 2.13145799 |
113 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.13139120 |
114 | Testicular atrophy (HP:0000029) | 2.13109580 |
115 | Vaginal atresia (HP:0000148) | 2.12340705 |
116 | Rimmed vacuoles (HP:0003805) | 2.11789966 |
117 | Absent speech (HP:0001344) | 2.11432700 |
118 | Patellar aplasia (HP:0006443) | 2.09335802 |
119 | Abnormal drinking behavior (HP:0030082) | 2.09290333 |
120 | Polydipsia (HP:0001959) | 2.09290333 |
121 | Cerebral edema (HP:0002181) | 2.08268958 |
122 | Round ear (HP:0100830) | 2.08092163 |
123 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.07477756 |
124 | Increased muscle lipid content (HP:0009058) | 2.06470523 |
125 | Generalized muscle weakness (HP:0003324) | 2.05671144 |
126 | Hyperammonemia (HP:0001987) | 2.05354191 |
127 | Sudden cardiac death (HP:0001645) | 2.04291335 |
128 | Acute necrotizing encephalopathy (HP:0006965) | 2.03896254 |
129 | Distal arthrogryposis (HP:0005684) | 2.02910863 |
130 | Hemiplegia (HP:0002301) | 2.02560961 |
131 | Hyperglycemia (HP:0003074) | 2.02526607 |
132 | Conjunctival hamartoma (HP:0100780) | 2.02506406 |
133 | Focal motor seizures (HP:0011153) | 2.01584692 |
134 | Toxemia of pregnancy (HP:0100603) | 2.00549689 |
135 | Muscular dystrophy (HP:0003560) | 1.99932281 |
136 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.99719514 |
137 | Blue irides (HP:0000635) | 1.98987605 |
138 | Cerebellar dysplasia (HP:0007033) | 1.98890882 |
139 | Widely spaced teeth (HP:0000687) | 1.98739010 |
140 | Stomach cancer (HP:0012126) | 1.97348138 |
141 | Limb-girdle muscle atrophy (HP:0003797) | 1.97199395 |
142 | * Congestive heart failure (HP:0001635) | 1.94392418 |
143 | Ragged-red muscle fibers (HP:0003200) | 1.93790404 |
144 | EMG: neuropathic changes (HP:0003445) | 1.93661999 |
145 | Acute encephalopathy (HP:0006846) | 1.93524338 |
146 | Hepatocellular necrosis (HP:0001404) | 1.93401345 |
147 | Severe muscular hypotonia (HP:0006829) | 1.93329685 |
148 | Long nose (HP:0003189) | 1.91949393 |
149 | Aplasia/Hypoplasia of the patella (HP:0006498) | 1.90967382 |
150 | Dialeptic seizures (HP:0011146) | 1.90530272 |
151 | Focal seizures (HP:0007359) | 1.90066116 |
152 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.88857691 |
153 | * Prominent supraorbital ridges (HP:0000336) | 1.88737848 |
154 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.88260524 |
155 | Nephrogenic diabetes insipidus (HP:0009806) | 1.88210732 |
156 | Concave nail (HP:0001598) | 1.85091068 |
157 | Hyperglycinuria (HP:0003108) | 1.85074655 |
158 | Bulbous nose (HP:0000414) | 1.83665818 |
159 | Abnormality of alanine metabolism (HP:0010916) | 1.83605776 |
160 | Hyperalaninemia (HP:0003348) | 1.83605776 |
161 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.83605776 |
162 | Bony spicule pigmentary retinopathy (HP:0007737) | 1.83600589 |
163 | Hyperkalemia (HP:0002153) | 1.82772911 |
164 | Abnormal ciliary motility (HP:0012262) | 1.82084594 |
165 | Spinal rigidity (HP:0003306) | 1.81608981 |
166 | Scapular winging (HP:0003691) | 1.79994603 |
167 | Poor coordination (HP:0002370) | 1.79849856 |
168 | Generalized aminoaciduria (HP:0002909) | 1.79844471 |
169 | Neuroendocrine neoplasm (HP:0100634) | 1.79803224 |
170 | Decreased central vision (HP:0007663) | 1.78478139 |
171 | Absence seizures (HP:0002121) | 1.78348958 |
172 | Polycythemia (HP:0001901) | 1.76315125 |
173 | Hypoplastic labia majora (HP:0000059) | 1.76218310 |
174 | Progressive macrocephaly (HP:0004481) | 1.76075538 |
175 | Hydroxyprolinuria (HP:0003080) | 1.76005857 |
176 | Abnormality of proline metabolism (HP:0010907) | 1.76005857 |
177 | Pulmonary artery stenosis (HP:0004415) | 1.75450257 |
178 | Distal lower limb amyotrophy (HP:0008944) | 1.74247678 |
179 | Abnormal biliary tract physiology (HP:0012439) | 1.73860382 |
180 | Bile duct proliferation (HP:0001408) | 1.73860382 |
181 | Lissencephaly (HP:0001339) | 1.73070154 |
182 | Bone cyst (HP:0012062) | 1.72920152 |
183 | Nausea (HP:0002018) | 1.72849559 |
184 | Gowers sign (HP:0003391) | 1.72617098 |
185 | Hamartoma of the eye (HP:0010568) | 1.68250819 |
186 | Central scotoma (HP:0000603) | 1.66923936 |
Rank | Gene Set | Z-score |
---|---|---|
1 | FRK | 8.11762265 |
2 | KDR | 5.18982207 |
3 | TTN | 5.05679615 |
4 | TIE1 | 4.86654776 |
5 | OBSCN | 4.63972710 |
6 | BMPR1B | 3.70117142 |
7 | ACVR1B | 3.60710664 |
8 | PHKG1 | 3.52495655 |
9 | PHKG2 | 3.52495655 |
10 | MYLK | 3.47760945 |
11 | ADRBK2 | 2.87769325 |
12 | LMTK2 | 2.86231720 |
13 | DMPK | 2.80965001 |
14 | PDK3 | 2.78128144 |
15 | PDK4 | 2.78128144 |
16 | PNCK | 2.49716737 |
17 | PKN2 | 2.30768691 |
18 | BCKDK | 2.24038271 |
19 | PDK2 | 2.02052388 |
20 | TRIB3 | 1.92677845 |
21 | PIK3CA | 1.89353755 |
22 | NTRK3 | 1.83374566 |
23 | MAPK13 | 1.70566664 |
24 | TGFBR2 | 1.69335055 |
25 | CASK | 1.65741555 |
26 | MAPK15 | 1.64799507 |
27 | STK24 | 1.64710576 |
28 | PINK1 | 1.62213228 |
29 | WNK3 | 1.59023077 |
30 | OXSR1 | 1.58707261 |
31 | ADRBK1 | 1.51759892 |
32 | INSRR | 1.46820088 |
33 | NEK1 | 1.46500254 |
34 | MUSK | 1.46374397 |
35 | PDGFRA | 1.30370086 |
36 | MARK1 | 1.30266300 |
37 | DAPK2 | 1.26770473 |
38 | MAPK12 | 1.15376150 |
39 | TNIK | 1.14362928 |
40 | MKNK2 | 1.14009652 |
41 | GRK7 | 1.13492995 |
42 | MAP3K4 | 1.11090233 |
43 | ZAK | 1.09903683 |
44 | MAP3K7 | 1.09886236 |
45 | PAK3 | 1.08074467 |
46 | PRKD1 | 1.06983805 |
47 | MAP4K2 | 1.06380867 |
48 | PRKAA2 | 1.05697626 |
49 | NUAK1 | 1.05118250 |
50 | CAMK4 | 1.03516829 |
51 | MAP2K3 | 1.03507251 |
52 | CAMKK2 | 1.03314909 |
53 | RIPK1 | 1.02120041 |
54 | TAOK3 | 0.97900411 |
55 | SIK1 | 0.93927865 |
56 | CAMK2D | 0.92515706 |
57 | FLT3 | 0.89229547 |
58 | ILK | 0.85425650 |
59 | PRKAA1 | 0.82502046 |
60 | ROCK1 | 0.82088838 |
61 | AKT3 | 0.80818345 |
62 | PTK2B | 0.80595584 |
63 | CDC42BPA | 0.76463960 |
64 | NTRK2 | 0.73425487 |
65 | IRAK1 | 0.73420804 |
66 | PRKCG | 0.72590546 |
67 | PIK3CG | 0.71807692 |
68 | JAK1 | 0.71801985 |
69 | EPHB1 | 0.71092098 |
70 | TRPM7 | 0.69318619 |
71 | NLK | 0.68017283 |
72 | NEK9 | 0.66984966 |
73 | TLK1 | 0.66411677 |
74 | ERN1 | 0.65838199 |
75 | WEE1 | 0.64062402 |
76 | CAMK1D | 0.63224669 |
77 | EPHB2 | 0.61994092 |
78 | PKN1 | 0.60587840 |
79 | STK11 | 0.59480142 |
80 | FGFR4 | 0.59229234 |
81 | PTK6 | 0.58559118 |
82 | STK38L | 0.57596168 |
83 | MAPKAPK5 | 0.57330074 |
84 | TGFBR1 | 0.56949846 |
85 | WNK4 | 0.56944989 |
86 | LATS1 | 0.55837714 |
87 | SGK2 | 0.55212710 |
88 | CAMK1G | 0.52226636 |
89 | MAP3K3 | 0.50190380 |
90 | STK3 | 0.49533817 |
91 | CAMK2A | 0.49469100 |
92 | FER | 0.48720137 |
93 | CAMK1 | 0.47088142 |
94 | STK4 | 0.45777350 |
95 | MAPK7 | 0.44478975 |
96 | PRKCH | 0.43804118 |
97 | TEC | 0.43187409 |
98 | MELK | 0.43001569 |
99 | PRKACB | 0.41974870 |
100 | CHUK | 0.41317258 |
101 | MAP3K5 | 0.41061793 |
102 | PRKCE | 0.40122221 |
103 | MAP2K6 | 0.39874994 |
104 | JAK2 | 0.39181934 |
105 | DAPK3 | 0.38171119 |
106 | PRKACG | 0.38117485 |
107 | MAPKAPK3 | 0.37896419 |
108 | RET | 0.37634498 |
109 | WNK1 | 0.36577187 |
110 | CAMK2G | 0.36282385 |
111 | PRKG2 | 0.36229042 |
112 | MAP2K4 | 0.33719899 |
113 | STK39 | 0.33648265 |
114 | MAP2K7 | 0.33181021 |
115 | PDPK1 | 0.32641638 |
116 | FGFR3 | 0.32458312 |
117 | PDGFRB | 0.32302501 |
118 | ERBB2 | 0.31599094 |
119 | RPS6KL1 | 0.29904225 |
120 | RPS6KC1 | 0.29904225 |
121 | * PRKACA | 0.29775066 |
122 | KIT | 0.29733453 |
123 | ROCK2 | 0.29555814 |
124 | STK38 | 0.29485438 |
125 | NEK2 | 0.29395643 |
126 | SIK2 | 0.28859229 |
127 | PRKCZ | 0.28233765 |
128 | FGFR2 | 0.28079666 |
129 | CAMK2B | 0.28060524 |
130 | CDK3 | 0.27835275 |
131 | PRKCA | 0.27411981 |
132 | BRSK2 | 0.27132444 |
133 | EPHA3 | 0.27121946 |
134 | PRKCQ | 0.26268832 |
135 | SGK494 | 0.26130955 |
136 | SGK223 | 0.26130955 |
137 | MAPK11 | 0.25414049 |
138 | AKT2 | 0.25249402 |
139 | RPS6KA3 | 0.24926355 |
140 | RPS6KA6 | 0.24712885 |
141 | PRKG1 | 0.24092867 |
142 | PAK2 | 0.22062028 |
143 | PDK1 | 0.21462340 |
144 | MAP2K1 | 0.19949027 |
145 | GRK1 | 0.19943457 |
146 | NME1 | 0.19118365 |
147 | SGK3 | 0.18863877 |
148 | MET | 0.16488959 |
149 | MTOR | 0.14712850 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 5.06567258 |
2 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 3.82190443 |
3 | Propanoate metabolism_Homo sapiens_hsa00640 | 3.48816160 |
4 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 3.33316963 |
5 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.31596349 |
6 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 3.26384631 |
7 | Fatty acid degradation_Homo sapiens_hsa00071 | 3.25404203 |
8 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 3.17893097 |
9 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.70653786 |
10 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.52245766 |
11 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 2.41736439 |
12 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 2.38541213 |
13 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 2.31452583 |
14 | Nicotine addiction_Homo sapiens_hsa05033 | 2.18517054 |
15 | Carbon metabolism_Homo sapiens_hsa01200 | 2.16997485 |
16 | Phototransduction_Homo sapiens_hsa04744 | 2.16510130 |
17 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 2.08045423 |
18 | Selenocompound metabolism_Homo sapiens_hsa00450 | 2.02942183 |
19 | Parkinsons disease_Homo sapiens_hsa05012 | 1.94455528 |
20 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.91605875 |
21 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.86165872 |
22 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.81161641 |
23 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.79387173 |
24 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.79346026 |
25 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.77111027 |
26 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.76892133 |
27 | Morphine addiction_Homo sapiens_hsa05032 | 1.73892750 |
28 | Histidine metabolism_Homo sapiens_hsa00340 | 1.72804433 |
29 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.68898407 |
30 | Taste transduction_Homo sapiens_hsa04742 | 1.62316334 |
31 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.61553729 |
32 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.56936316 |
33 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.52187102 |
34 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.51800131 |
35 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.48903380 |
36 | Alzheimers disease_Homo sapiens_hsa05010 | 1.48760727 |
37 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.44352850 |
38 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.42068910 |
39 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.40934433 |
40 | Olfactory transduction_Homo sapiens_hsa04740 | 1.38533721 |
41 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.37770181 |
42 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.36145182 |
43 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.35525863 |
44 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.32769737 |
45 | GABAergic synapse_Homo sapiens_hsa04727 | 1.31377414 |
46 | Viral myocarditis_Homo sapiens_hsa05416 | 1.30875170 |
47 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.27720917 |
48 | Insulin resistance_Homo sapiens_hsa04931 | 1.26822432 |
49 | Retinol metabolism_Homo sapiens_hsa00830 | 1.26312854 |
50 | Salivary secretion_Homo sapiens_hsa04970 | 1.26067041 |
51 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.20473915 |
52 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.20347413 |
53 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.15607618 |
54 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.15077411 |
55 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.11188762 |
56 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.09240640 |
57 | Focal adhesion_Homo sapiens_hsa04510 | 1.06952532 |
58 | Huntingtons disease_Homo sapiens_hsa05016 | 1.06309796 |
59 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.03186886 |
60 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.02070781 |
61 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.97359036 |
62 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.96726515 |
63 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.96518356 |
64 | Lysine degradation_Homo sapiens_hsa00310 | 0.96392391 |
65 | Cocaine addiction_Homo sapiens_hsa05030 | 0.95891049 |
66 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.95321023 |
67 | Peroxisome_Homo sapiens_hsa04146 | 0.93826398 |
68 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.93136374 |
69 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.91231104 |
70 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.90340180 |
71 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.89928026 |
72 | Long-term depression_Homo sapiens_hsa04730 | 0.87140809 |
73 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.86718383 |
74 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.86425917 |
75 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.83188384 |
76 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.83179980 |
77 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.79854054 |
78 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.79686206 |
79 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.79347968 |
80 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.79322749 |
81 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.78224774 |
82 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.73991275 |
83 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.73728014 |
84 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.72558384 |
85 | Bile secretion_Homo sapiens_hsa04976 | 0.71116063 |
86 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.70991455 |
87 | Mineral absorption_Homo sapiens_hsa04978 | 0.69749672 |
88 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.68773142 |
89 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.67740576 |
90 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.66297424 |
91 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.65292344 |
92 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.60144176 |
93 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.60112208 |
94 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.57397339 |
95 | Renin secretion_Homo sapiens_hsa04924 | 0.57297631 |
96 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.56338092 |
97 | Adherens junction_Homo sapiens_hsa04520 | 0.51542779 |
98 | Homologous recombination_Homo sapiens_hsa03440 | 0.51254313 |
99 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.50953437 |
100 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.50058159 |
101 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.48954069 |
102 | Tight junction_Homo sapiens_hsa04530 | 0.48345150 |
103 | Amoebiasis_Homo sapiens_hsa05146 | 0.45759783 |
104 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.44845709 |
105 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.43437789 |
106 | Circadian rhythm_Homo sapiens_hsa04710 | 0.42912836 |
107 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.42883231 |
108 | Galactose metabolism_Homo sapiens_hsa00052 | 0.42302222 |
109 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.42111123 |
110 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.40128510 |
111 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.38451076 |
112 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.38323434 |
113 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.37778796 |
114 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.36594133 |
115 | Sulfur relay system_Homo sapiens_hsa04122 | 0.35230283 |
116 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.34546737 |
117 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.34447534 |
118 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.34026922 |
119 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.34003941 |
120 | Malaria_Homo sapiens_hsa05144 | 0.33973150 |
121 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.33879433 |
122 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.33753596 |
123 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.32185065 |
124 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.31781978 |
125 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.31665922 |
126 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.30979775 |
127 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.30406482 |
128 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.29824618 |
129 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.29715876 |
130 | Platelet activation_Homo sapiens_hsa04611 | 0.29370191 |
131 | Insulin secretion_Homo sapiens_hsa04911 | 0.28600773 |
132 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.28349870 |
133 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.28200110 |
134 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.28025319 |
135 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.27255318 |
136 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.23506213 |
137 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.23500962 |
138 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.23362449 |
139 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.19722939 |
140 | * ABC transporters_Homo sapiens_hsa02010 | 0.19547396 |
141 | Metabolic pathways_Homo sapiens_hsa01100 | 0.18811602 |
142 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.17843751 |
143 | Circadian entrainment_Homo sapiens_hsa04713 | 0.17354837 |
144 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.16337181 |
145 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.15620011 |
146 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.15188052 |
147 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.14349976 |
148 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.13873395 |